Find clinical trials for Diabetes in Madrid, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus

Type 2 Diabetes Mellitus

Type 1 Diabetes Mellitus

Diabetic Foot

Foot Ulcer

Ulcer

Obesity

Diabetes trials near Madrid, MD, ESP:

A Phase III Study to Investigate If the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed with Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling

Type 1 Diabetes Mellitus

Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®

Biological: Placebo

Phase 3

Diamyd Medical

Madrid, Spain and 59 other locations

Safety and Initial Performance of the DiaGone Device on Type 2 Diabetes Patients

This is a multi-center, prospective, open label study of the Duodenal Glycemic Control™ procedure on type 2 diabetes patients sub-optimally ...

Enrolling

Diabetes Mellitus, Type 2

Device: DiaGone™

Digma Medical

Madrid, Spain and 4 other locations

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting

Type 2 Diabetes Mellitus

Drug: Tirzepatide

Drug: Dulaglutide

Phase 3

Lilly

Madrid, Madrid, Comunidad De, Spain and 652 other locations

Locations recently updated

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling

Diabetes Mellitus, Type 2

Drug: AZD5004

Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca

Madrid, Spain and 103 other locations

A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients (STRIDE)

The goal of this study is to determine if treatment with TCD601 improves beta-cell function in adults recently diagnosed with type 1 diabetes...

Active, not recruiting

Diabetes Mellitus, Type 1

Other: Placebo

Biological: TCD601

Phase 2

ITBMed

Segovia, Spain and 37 other locations

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doct...

Enrolling

Type 2 Diabetes (T2D)

Drug: Placebo (NNC0487-0111 oral)

Drug: NNC0487-0111 oral

Phase 2

Novo Nordisk

Madrid, Spain and 94 other locations

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2)

The purpose of this study is to is to evaluate the efficacy and safety of retatrutide in participants with type 2 diabetes in participants w...

Active, not recruiting

Type 2 Diabetes

Overweight

Drug: Placebo

Drug: Retatrutide

Phase 3

Lilly

Madrid, Madrid, Comunidad De, Spain and 101 other locations

Locations recently updated

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight (SYNCHRONIZE™-2)

index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exer...

Active, not recruiting

Diabetes Mellitus, Type 2

Obesity

Drug: Survodutide

Drug: Placebo

Phase 3

Boehringer Ingelheim

Madrid, Spain and 146 other locations

Status recently updated

A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes

The study medicine will be investigated in participants with type 2 diabetes. Participants will either get insulin icodec or insulin glargin...

Enrolling

Active, not recruiting

Diabetes, Type 2

Drug: Insulin glargine

Drug: Insulin icodec

Phase 3

Novo Nordisk

Pozuelo de Alarcón, Spain and 71 other locations

Locations recently updated

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

to a higher dose of insulin glargine in participants with type 2 diabetes. The study looks at how well the study medicines control blood glu...

Active, not recruiting

Diabetes Mellitus, Type 2

Obesity

Drug: Insuline glargine U100 (titrated)

Drug: Insuline glargine U100 (reduced)

Phase 3

Novo Nordisk

Sevilla, Spain and 116 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Diabetes in .css-epvm6{white-space:nowrap;}Madrid, MD

Related conditions:

Diabetes trials near Madrid, MD, ESP:

A Phase III Study to Investigate If the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed with Type 1 Diabetes (DIAGNODE-3)

Safety and Initial Performance of the DiaGone Device on Type 2 Diabetes Patients

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients (STRIDE)

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight (TRIUMPH-2)

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight (SYNCHRONIZE™-2)

A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

Find clinical trials for Diabetes in Madrid, MD